statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Watchers	17,830
52-Wk Low	$1.04
52-Wk High	$3.23

Volume	306,186.00
52-Wk High	$3.23
52-Wk Low	$1.04

Period	Estimated	Reported	Surprise	Result
Q2'24	--	-$0.14	--	N/A
Q1'24	--	-$0.14	--	N/A
Q4'23	--	$0.21	--	N/A
Q3'23	-$0.15	-$0.57	-280.00%	MISSED
Q2'23	-$0.17	-$0.19	-11.76%	MISSED

CVM Cel-Sci Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals